Zobrazeno 1 - 10
of 255
pro vyhledávání: '"Pierre Gobin"'
Publikováno v:
PLoS ONE, Vol 13, Iss 6, p e0196275 (2018)
PURPOSE:Magnetic resonance venography (MRV) has not been validated in pre-operative planning of the dural venous sinus stenting (VSS) among idiopathic intracranial hypertension (IIH) patients. We aim to prospectively evaluate dural venous sinus measu
Externí odkaz:
https://doaj.org/article/d8214bcb951a4eff93c89caa9876a569
Autor:
Paula Taich, Flavio Requejo, Marcelo Asprea, Mariana Sgroi, Pierre Gobin, David H Abramson, Guillermo Chantada, Paula Schaiquevich
Publikováno v:
PLoS ONE, Vol 11, Iss 3, p e0151343 (2016)
Extraocular retinoblastoma is a major challenge worldwide, especially in developing countries. Current treatment involves the administration of systemic chemotherapy combined with radiation, but there is a clear need for improvement of chemotherapy b
Externí odkaz:
https://doaj.org/article/ceed42ac6da14534b9f2cd00401eab76
Autor:
Jasmine H. Francis, MD, Y. Pierre Gobin, MD, A. Rose Brannon, PhD, Christina E. Swartzwelder, RPA-C, Michael F. Berger, PhD, Diana L. Mandelker, MD, PhD, Michael F. Walsh, MD, Ira J. Dunkel, MD, David H. Abramson, MD
Publikováno v:
Ophthalmology Science, Vol 1, Iss 3, Pp 100042- (2021)
Purpose: Circulating tumor DNA (ctDNA) is released by many tumors into the plasma. Its analysis has minimal procedural risk and, in many cancers, has the potential for clinical applications. In retinoblastoma, the clinical correlations of ctDNA in ey
Externí odkaz:
https://doaj.org/article/f77d86aaaa2a4d9e9c72b410c8c8ab98
Autor:
Kelley J. Bohm, Y. Pierre Gobin, Jasmine H. Francis, Gabrielle McInerney, Anahita Dabo-Trubelja, Paul H. Dalecki, Brian P. Marr, David H. Abramson
Publikováno v:
International Journal of Retina and Vitreous, Vol 4, Iss 1, Pp 1-5 (2018)
Abstract Background Methylenetetrahydrofolate reductase (MTHFR) genetic mutations and intra-procedural inhaled nitrous oxide (N2O) independently increase blood levels of homocysteine, a compound associated with thrombosis. Patients with MTHFR mutatio
Externí odkaz:
https://doaj.org/article/efc3ca7049c24e6599231d6de4e40c0f
Autor:
David H. Abramson, Carol L. Shields, Pascal Jabbour, Luiz Fernando Teixeira, José Roberto Falco Fonseca, Marcio Chaves Pedro Marques, Francis L. Munier, Francesco Puccinelli, Theodora Hadjistilianou, Sandra Bracco, Guillermo Chantada, Alejandro Ceciliano, Y. Pierre Gobin
Publikováno v:
International Journal of Retina and Vitreous, Vol 3, Iss 1, Pp 1-4 (2017)
Abstract Background Ophthalmic artery chemosurgery [OAC, intra-arterial chemotherapy (IAC)] was introduced in 2006 as treatment modality for intraocular retinoblastoma. The purpose of this commentary is to retrospectively review the incidence of meta
Externí odkaz:
https://doaj.org/article/22225d1fbbed4b4b92aa0242a3efb8f5
Autor:
Priya H. Marathe, Ira J. Dunkel, Jasmine H. Francis, Zoltan Antal, Y. Pierre Gobin, David H. Abramson, Danielle N. Friedman
Publikováno v:
Ophthalmic Genetics. 43:806-808
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5c69c4eaf808db919f9bfe1a5979b254
https://doi.org/10.1080/13816810.2022.2132516
https://doi.org/10.1080/13816810.2022.2132516
Autor:
Ariana M Levin, Jasmine H Francis, Molly McFadden, Scott Brodie, Y Pierre Gobin, David H Abramson
Publikováno v:
PLoS ONE, Vol 14, Iss 1, p e0210647 (2019)
ImportancePredictions of visual outcomes are useful in clinical and family decisions regarding treatment for retinoblastoma. Very little has been published on the association of post-treatment visual acuity with pre-treatment electroretinography (ERG
Externí odkaz:
https://doaj.org/article/c036352f966a4fd8a5741439836c80ac
Autor:
Foley, Conor P., Rubin, David G., Santillan, Alejandro, Sondhi, Dolan, Dyke, Jonathan P., Pierre Gobin, Y., Crystal, Ronald G., Ballon, Douglas J.
Publikováno v:
In Journal of Controlled Release 28 December 2014 196:71-78
Publikováno v:
Ophthalmol Retina
Retinoblastoma eyes with choroidal invasion may not have to be enucleated and may be successfully managed with OAC using Melphalan, Carboplatin and Topotecan without compromising patient survival.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c96718786cb5069ab8e16a8c91cafd2
https://doi.org/10.1016/j.oret.2020.12.018
https://doi.org/10.1016/j.oret.2020.12.018
Autor:
Sruti S Akella, Jasmine H Francis, Andrea Knezevic, Irina Ostrovnaya, Y Pierre Gobin, Danielle Friedman, Edith Guarini, Lindsey Eibeler, Federica Catalanotti, David H Abramson
Publikováno v:
PLoS ONE, Vol 13, Iss 5, p e0197052 (2018)
Although studies from pediatric cancers (largely acute lymphoblastic leukemia) have shown that patients undergoing systemic chemotherapy may experience decreased growth velocity during the treatment phase, no such data exist for retinoblastoma patien
Externí odkaz:
https://doaj.org/article/8754b02c74f841ca93c7583988f2db38